Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Cybulla

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Reviews. Cancer|November 3, 2022
Leveraging the replication stress response to optimize cancer therapyEmily Cybulla, Alessandro Vindigni
Frontiers in Oncology|November 26, 2025
Circulating DNA tumor fraction as a biomarker for advanced breast cancerEmily Cybulla, Daniel G Stover
Critical Reviews in Biochemistry and Molecular Biology|November 12, 2020
PRIMPOL ready, set, reprime!Stephanie Tirman, Emily Cybulla, Annabel Quinet, et al.
Molecular Cell|January 30, 2021
To skip or not to skip: choosing repriming to tolerate DNA damageAnnabel Quinet, Stephanie Tirman, Emily Cybulla, et al.
Molecular Cell|October 8, 2021
Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cellsStephanie Tirman, Annabel Quinet, Matthew Wood, et al.
Cell Reports|February 22, 2018
A Cell-Intrinsic Interferon-like Response Links Replication Stress to Cellular Aging Caused by ProgerinRay Kreienkamp, Simona Graziano, Nuria Coll-Bonfill, et al.
Prostate Cancer|December 26, 2024
Number of Prescription Medications and Overall Survival in Metastatic Castrate-Resistant Prostate CancerCarley R Pickett, Daniel B Eaton, Krishny Karunanandaa, et al.
Nucleic Acids Research|June 29, 2024
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cellsEmily Cybulla, Sierra Wallace, Alice Meroni, et al.
Molecular Cell|November 3, 2019
PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient CellsAnnabel Quinet, Stephanie Tirman, Jessica Jackson, et al.
Gynecologic Oncology|April 19, 2021
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancerVijayalaxmi G Gupta, Jeff Hirst, Shariska Petersen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Reviews. Cancer|November 3, 2022
Leveraging the replication stress response to optimize cancer therapyEmily Cybulla, Alessandro Vindigni
Frontiers in Oncology|November 26, 2025
Circulating DNA tumor fraction as a biomarker for advanced breast cancerEmily Cybulla, Daniel G Stover
Critical Reviews in Biochemistry and Molecular Biology|November 12, 2020
PRIMPOL ready, set, reprime!Stephanie Tirman, Emily Cybulla, Annabel Quinet, et al.
Molecular Cell|January 30, 2021
To skip or not to skip: choosing repriming to tolerate DNA damageAnnabel Quinet, Stephanie Tirman, Emily Cybulla, et al.
Molecular Cell|October 8, 2021
Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cellsStephanie Tirman, Annabel Quinet, Matthew Wood, et al.
Cell Reports|February 22, 2018
A Cell-Intrinsic Interferon-like Response Links Replication Stress to Cellular Aging Caused by ProgerinRay Kreienkamp, Simona Graziano, Nuria Coll-Bonfill, et al.
Prostate Cancer|December 26, 2024
Number of Prescription Medications and Overall Survival in Metastatic Castrate-Resistant Prostate CancerCarley R Pickett, Daniel B Eaton, Krishny Karunanandaa, et al.
Nucleic Acids Research|June 29, 2024
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cellsEmily Cybulla, Sierra Wallace, Alice Meroni, et al.
Molecular Cell|November 3, 2019
PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient CellsAnnabel Quinet, Stephanie Tirman, Jessica Jackson, et al.
Gynecologic Oncology|April 19, 2021
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancerVijayalaxmi G Gupta, Jeff Hirst, Shariska Petersen, et al.
Pageof 2